🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent discussion, waiting for the ipi/nivo presentation tomorrow #ESMO22

Outstanding talk by my mentor Jonathan Rosenberg MD on EV+Pembro in 1st line cis-ineligible mUC, and great discussion by Dr. Albiges

Thank you Paris, it’s been amazing #ESMO22

Uromigos #asco25 Unsung Hero Poster Award for bladder cancer. Michal Sternschuss presents some data for outcomes of therapy after EVP. Watch to the end for the applause!

Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in pts with metastatic urothelial carcinoma in ESMO Open. In a large RW cohort, treatment with SG after prior EV resulted in limited clinical efficacy. esmoopen.com/article/S2059-…